We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Image: Seye Oladeji, graduate student and first author, holds up an example of a detection assay. (Photo courtesy of Rice University/Jared Jones)

New RNA Detection Tool Shows Promise for HIV and Other Viral Testing

A new CRISPR-based enzyme delivers more sensitive RNA detection while remaining heat-stable. More...
14 Oct 2026
Image: TissueCypher analyzes protein biomarkers and tissue architecture in biopsy samples to estimate five-year risk of progression to high-grade dysplasia or esophageal adenocarcinoma. (Photo courtesy of Castle Biosciences)

Molecular Testing Refines Barrett’s Esophagus Progression Risk Beyond Biopsy Findings

A molecular test estimates five-year risk of high-grade dysplasia or cancer in Barrett’s esophagus, guiding care beyond pathology. More...
14 Oct 2026
Image: The platform is designed to isolate extracellular vesicles originating from a selected tissue, with an initial focus on those released by hepatocytes in the liver. (Photo courtesy of Mursla Bio)

Tissue-Specific Vesicle Isolation Expands Molecular Insights Into Liver Disease

Mursla Bio has published validation data for its tissue-specific extracellular vesicle platform, built on NEXPLOR technology. More...
14 Oct 2026
Image: The acquisition of Proscia advances Agilent’s efforts to expand its pathology portfolio and strengthens its competitive position in a rapidly growing market.

Agilent Acquisition of Proscia to Advance AI-Enabled Digital Pathology Workflows

Agilent Technologies has entered into a definitive agreement to acquire Proscia, a provider of digital pathology software for clinical and life-sciences customers.  More...
14 Oct 2026
Image: Diazyme Laboratories has acquired Alfa Wassermann Diagnostic Technologies (AWDT), an FDA-registered manufacturer of chemistry systems and reagents, from CARR Biosystems

Diazyme Expands Chemistry Testing Portfolio With Alfa Wassermann Acquisition

Diazyme Laboratories, Inc. has acquired the business of Alfa Wassermann Diagnostic Technologies LLC  from CARR Biosystems. More...
14 Oct 2026
Image: AISight Dx is a cloud-native digital pathology platform that streamlines case management, slide review, and collaboration to improve anatomic pathology workflows (Photo courtesy of PathAI)

Digital Pathology Collaboration Expands Laboratory Access to AI-Driven Diagnostics

An AI platform integration embeds digital pathology models into case workflows, expanding access to diagnostic decision support. More...
14 Oct 2026
Image Credit: iStock

Blood Protein May Help Identify Treatment-Resistant Psychosis

New findings identify a potential blood biomarker for treatment-resistant psychosis that could help guide treatment decisions. More...
14 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Copyright © 2000-2026 Globetech Media. All rights reserved.